EUVIMEDEUVIMED entdecken
Crossref

Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience

Kaidi Wang, Pouya Sabouri, Adam Wolfe, Eric Siegel, John Marrufo, Canon Cothran, Paula McClain, Gary Lewis, Jose Penagaricano, Robert J Griffin, Fen Xia

International Journal of Radiation Oncology*Biology*Physics · 2026-01 · 124 (1) · 147-158

DOI: 10.1016/j.ijrobp.2025.08.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-01. Verfasst von Kaidi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Ohio State University, Columbus, Ohio. Electronic address: kaidi.wang@osumc.edu. Hauptthemen laut MEDLINE: Dose Fractionation, Radiation, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Spatially fractionated radiation therapy, specifically grid radiation therapy (grid-RT), is a treatment option for bulky tumors (≥6 cm). However, its modern use for locally advanced or metastatic disease remains limited. We evaluated outcomes in patients treated with grid-RT at our institution. METHODS AND MATERIALS: We retrospectively reviewed patients with locally advanced or metastatic bulky tumors treated with grid-RT from December 2013 to June 2022. Patient and treatment characteristics, response rates, survival outcomes, and toxicity were analyzed. RESULTS: Eighty patients underwent 82 grid-RT treatments. Median age was 58.5 years. The head and neck region was the most frequently treated site (40/82, 49%). The most common grid-RT dose was 20 Gy in a single fraction (78/82, 95%; range, 15-20). Median gross tumor volume was 364 cm3 (range, 46-3860). Most treatment courses (51/82, 62%) used a Cerrobend grid block, whereas 31 of 82 (38%) treatments used intensity modulated radiation therapy (IMRT) via tomotherapy. Median follow-up was 8 months (range, 1-100). Seventeen patients were lost to follow-up before imaging response assessment. Among 65 evaluable treatments, 53 demonstrated an objective response (82%). Definitive treatment intent and definitive RT dose were associated with improved response. Cumulative locoregional recurrences at 1, 2, and 3 years were 21% (95% CI, 11.1%-31.4%), 24% (95% CI, 12.7%-34.4%), and 26% (95% CI, 14.5%-37.9%), respectively. Median time to progression was 11.7 months (IQR, 5.9-35.8 months). Median progression-free survival was 5.7 months (95% CI, 3.3-6.9). Median overall survival was 7.9 months (95% CI, 5.1-11.6). Common acute toxicities included grade-2 radiation dermatitis (14/102, 14%) and grade-2 oral mucositis (13/102, 13%). Late toxicities (>30 days post-RT) included grade-1 fatigue (4/43, 10%), grade-2 pain (5/43, 12%), and grade-2 dry mouth (4/43, 10%). Grid block was associated with higher acute xerostomia than IMRT. CONCLUSIONS: Grid-RT appears to be an effective treatment for bulky tumors, either standalone or as a boost to palliative or definitive radiation. Grid block and IMRT have comparable short- and long-term toxicity profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dose Fractionation, RadiationNeoplasmsHumansMiddle AgedMaleFemaleRetrospective StudiesAgedAdultRadiotherapy, Intensity-ModulatedAged, 80 and overTumor BurdenHead and Neck NeoplasmsTreatment Outcome

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Ohio State University, Columbus, Ohio. Electronic address: kaidi.wang@osumc.edu.
  • Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Department of Radiation Oncology, Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, Texas.
  • Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.

Zitieren

APA

Wang, K., Sabouri, P., Wolfe, A., Siegel, E., Marrufo, J., Cothran, C., McClain, P., Lewis, G., Penagaricano, J., Griffin, R. J., & Xia, F. (2026). Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience. International Journal of Radiation Oncology*Biology*Physics, 124(1), 147-158. https://doi.org/10.1016/j.ijrobp.2025.08.013

Vancouver

Wang K, Sabouri P, Wolfe A, Siegel E, Marrufo J, Cothran C, et al. Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience. International Journal of Radiation Oncology*Biology*Physics. 2026;124(1):147-158. doi:10.1016/j.ijrobp.2025.08.013

BibTeX
@article{Wang2026,
  author = {Wang, Kaidi and Sabouri, Pouya and Wolfe, Adam and Siegel, Eric and Marrufo, John and Cothran, Canon and McClain, Paula and Lewis, Gary and Penagaricano, Jose and Griffin, Robert J and Xia, Fen},
  title = {Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {124},
  number = {1},
  pages = {147--158},
  doi = {10.1016/j.ijrobp.2025.08.013}
}
Kostenlos starten →